Deletions of the transcription factor Ikaros in myeloproliferative neoplasms

被引:103
作者
Jaeger, R. [1 ]
Gisslinger, H. [2 ]
Passamonti, F. [3 ]
Rumi, E. [3 ]
Berg, T. [1 ]
Gisslinger, B. [2 ]
Pietra, D. [3 ]
Harutyunyan, A. [1 ]
Klampfl, T. [1 ]
Olcaydu, D. [1 ]
Cazzola, M. [3 ]
Kralovics, R. [1 ,2 ]
机构
[1] Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria
[2] Med Univ Vienna, Div Hematol & Blood Coagulat, Dept Internal Med 1, Vienna, Austria
[3] Univ Pavia, Div Hematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
基金
奥地利科学基金会;
关键词
JAK2-V617F; oncogene; tumor suppressor; monosomy; 7; IKZF1; acute myeloid leukemia; MPL-W515L; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE JAK2; ACTIVATING MUTATION; MYELOID METAPLASIA; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; SOMATIC MUTATIONS; DISORDERS; GENE; TRANSFORMATION;
D O I
10.1038/leu.2010.99
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transformation to acute leukemia is a major complication of myeloproliferative neoplasms (MPNs), however, the genetic changes leading to transformation remain largely unknown. We screened nine patients with post-MPN leukemia for chromosomal aberrations using microarray karyotyping. Deletions on the short arm of chromosome 7 (del7p) emerged as a recurrent defect. We mapped the common deleted region to the IKZF1 gene, which encodes the transcription factor Ikaros. We further examined the frequency of IKZF1 deletions in a total of 29 post-MPN leukemia and 526 MPN patients without transformation and observed a strong association of IKZF1 deletions with post-MPN leukemia in two independent cohorts. Patients with IKZF1 loss showed complex karyotypes, and del7p was a late event in the genetic evolution of the MPN clone. IKZF1 deletions were observed in both undifferentiated and differentiated myeloid cell types, indicating that IKZF1 loss does not cause differentiation arrest but rather renders progenitors susceptible to transformation, most likely through chromosomal instability. Induced Ikzf1 haploinsufficiency in primary murine progenitors resulted in elevated Stat5 phosphorylation and increased cytokine-dependent growth, suggesting that reduced expression of IKZF1 is sufficient to perturb growth regulation. Thus, IKZF1 loss is an important step in the leukemic transformation of a subpopulation of MPN patients. Leukemia (2010) 24, 1290-1298; doi:10.1038/leu.2010.99; published online 27 May 2010
引用
收藏
页码:1290 / 1298
页数:9
相关论文
共 43 条
[11]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[12]   Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMAALWP) [J].
Iacobucci, Ilaria ;
Storlazzi, Clelia Tiziana ;
Cilloni, Daniela ;
Lonetti, Annalisa ;
Ottaviani, Emanuela ;
Soverini, Simona ;
Astolfi, Annalisa ;
Chiaretti, Sabina ;
Vitale, Antonella ;
Messa, Francesca ;
Impera, Luciana ;
Baldazzi, Carmen ;
D'Addabbo, Pietro ;
Papayannidis, Cristina ;
Lonoce, Angelo ;
Colarossi, Sabrina ;
Vignetti, Marco ;
Piccaluga, Pier Paolo ;
Paolini, Stefania ;
Russo, Domenico ;
Pane, Fabrizio ;
Saglio, Giuseppe ;
Baccarani, Michele ;
Foa, Robin ;
Martinelli, Giovanni .
BLOOD, 2009, 114 (10) :2159-2167
[13]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[14]   Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels [J].
Kano, Gen ;
Morimoto, Akira ;
Takanashi, Mami ;
Hibi, Shigeyoshi ;
Sugimoto, Tohru ;
Inaba, Tohru ;
Yagi, Tomohito ;
Imashuku, Shinsaku .
LEUKEMIA & LYMPHOMA, 2008, 49 (05) :965-973
[15]   Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia [J].
Kearney, Lyndal ;
De Castro, David Gonzalez ;
Yeung, Jenny ;
Procter, Julia ;
Horsley, Sharon W. ;
Eguchi-Ishimae, Minenori ;
Bateman, Caroline M. ;
Anderson, Kristina ;
Chaplin, Tracy ;
Young, Bryan D. ;
Harrison, Christine J. ;
Kempski, Helena ;
So, Chi Wai E. ;
Ford, Anthony M. ;
Greaves, Mel .
BLOOD, 2009, 113 (03) :646-648
[16]  
Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO
[17]  
2-P
[18]   Genetic complexity of myeloproliferative neoplasms [J].
Kralovics, R. .
LEUKEMIA, 2008, 22 (10) :1841-1848
[19]   A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].
Kralovics, R ;
Passamonti, F ;
Buser, AS ;
Teo, S ;
Tiedt, R ;
Passweg, JR ;
Tichelli, A ;
Cazzola, M ;
Skoda, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790
[20]   Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders [J].
Kralovics, Robert ;
Teo, Soon-Siong ;
Li, Sai ;
Theocharides, Alexandre ;
Buser, Andreas S. ;
Tichelli, Andre ;
Skoda, Radek G. .
BLOOD, 2006, 108 (04) :1377-1380